Francesco Galimi
Förmögenhet: - $ per 2026-05-31
Förmögenhet: - $ per 2026-05-31
Francesco Galimi currently works at Genenta Science SpA, as Director from 2025 and Adicet Therapeutics, Inc., as Chief Medical Officer & Senior Vice President from 2019.
Dr. Galimi also formerly worked at Amgen, Inc., as General Manager-Global Program from 2015 to 2019, Onyx Pharmaceuticals, Inc., as Head-Clinical Development from 2014 to 2015, resTORbio, Inc., as Chief Medical Officer & Senior Vice President, and Adicet Bio, Inc., as Chief Medical Officer & Senior Vice President from 2019 to 2025.
Dr. Galimi received his doctorate degree from the University of Torino School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
GENENTA SCIENCE SPA -.--% | 2026-03-30 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| GENENTA SCIENCE S.P.A. | Direktör/Styrelseledamot | 2025-01-01 |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Teknisk/Vetenskaplig/F&U Direktör | 2019-09-01 |
| Företag | Position | Slut |
|---|---|---|
| ADICET BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-01-13 |
| AMGEN INC. | Företagsledare/Principal | 2019-01-01 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Företagsledare/Principal | 2015-01-01 |
| ADICET BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
resTORbio, Inc.
resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån